Spots Global Cancer Trial Database for giant cell tumor of bone
Every month we try and update this database with for giant cell tumor of bone cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone | NCT03295981 | Giant Cell Tumo... | Zoledronic Acid | 18 Years - | St. Louis University | |
| Study of Denosumab in Subjects With Giant Cell Tumor of Bone | NCT00680992 | Cancer Giant Cell Tumo... Giant Cell Tumo... Benign Giant Ce... | Denosumab | 12 Years - | Amgen | |
| LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas | NCT03449108 | Bone Sarcoma Dedifferentiate... Giant Cell Tumo... Malignancy in G... Malignant Solid... Ovarian Carcino... Platinum-Resist... Poorly Differen... Recurrent Osteo... Recurrent Ovari... Refractory Oste... Soft Tissue Sar... Thyroid Gland A... Thyroid Gland S... Undifferentiate... Triple Negative... | Aldesleukin Autologous Tumo... Autologous Tumo... Cyclophosphamid... Fludarabine Ipilimumab Nivolumab Quality-of-Life... Questionnaire A... | 16 Years - 70 Years | M.D. Anderson Cancer Center | |
| Adjuvant Zoledronic Acid in High Risk Giant Cell Tumour of Bone (GCT) | NCT00889590 | Giant Cell Tumo... Osteoclastoma | Zoledronic acid | 18 Years - | Leiden University Medical Center | |
| Giant Cell Tumor of the Bone in Young Patients | NCT04002817 | Giant Cell Tumo... | - 15 Years | Istituto Ortopedico Rizzoli | ||
| Safety and Efficacy of Post-operative Denosumab Strategy for Giant Cell Tumor of Bone Treatment in China | NCT03358212 | Giant Cell Tumo... | Denosumab | 16 Years - 50 Years | Peking University People's Hospital | |
| Zoledronic Acid-loaded Bone Cement as a Local Adjuvant Therapy for Giant Cell Bone Tumor After Intralesional Curettage | NCT05595603 | Giant Cell Tumo... | 4mg ZOL loaded ... gentamicin PMMA | - | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| The Value of Preoperative Diagnosis and Prognostic Prediction Based on Radiomics of Giant Cell Tumor of Spine | NCT04952818 | Spinal Tumor | RANK/RANKL(RANK... | 1 Year - 100 Years | Peking University Third Hospital | |
| Study of XGEVA® (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the Bone | NCT04586660 | Giant Cell Tumo... | XGEVA® | 12 Years - | Amgen | |
| Giant Cell Tumor of the Bone in Young Patients | NCT04002817 | Giant Cell Tumo... | - 15 Years | Istituto Ortopedico Rizzoli | ||
| Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone | NCT03295981 | Giant Cell Tumo... | Zoledronic Acid | 18 Years - | St. Louis University | |
| Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004 | NCT03301857 | Giant Cell Tumo... | Denosumab | - | Amgen | |
| Adjuvant Zoledronic Acid in High Risk Giant Cell Tumour of Bone (GCT) | NCT00889590 | Giant Cell Tumo... Osteoclastoma | Zoledronic acid | 18 Years - | Leiden University Medical Center | |
| A Real-world Study on Patients of Unresectable Giant Cell Tumor of Bone | NCT05402865 | Giant Cell Tumo... | Denosumab | 18 Years - | Shanghai JMT-Bio Inc. | |
| Giant Cell Tumor of the Extremities Treated With Surgery and/or Medical Treatment | NCT02996734 | Giant Cell Tumo... | curettage and r... | - | Istituto Ortopedico Rizzoli | |
| Study of Denosumab in Subjects With Giant Cell Tumor of Bone | NCT00680992 | Cancer Giant Cell Tumo... Giant Cell Tumo... Benign Giant Ce... | Denosumab | 12 Years - | Amgen | |
| A Study to Evaluate the Efficacy and Safety of Narlumosbart (JMT103) in Patients With Giant Cell Tumor of Bone | NCT05813665 | Giant Cell Tumo... | Narlumosbart Denosumab | 12 Years - | Shanghai JMT-Bio Inc. | |
| Zoledronic Acid-loaded Bone Cement as a Local Adjuvant Therapy for Giant Cell Bone Tumor After Intralesional Curettage | NCT05595603 | Giant Cell Tumo... | 4mg ZOL loaded ... gentamicin PMMA | - | Second Affiliated Hospital, School of Medicine, Zhejiang University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
